Perhaps timely catching Xerox Holdings Corp (XRX) would be a good idea

With 1.26 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.55 shares. During the session, the Information Technology Services company that operates in wider Technology sector, reached to the highest price of $18.62 whereas the lowest price it dropped to was $18.26. The 52-week range on XRX shows that it touched its highest point at $19.78 and its lowest point at $12.06 during that stretch. It currently has a 1-year price target of $16.48. With its current market cap of 2.27 billion, XRX has annualized dividend of $1.00 (5.41%) while the current yield stands at 1.00 (5.41%). Beta for the stock currently stands at 1.59.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.

Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of XRX was up-trending over the past week, with a rise of 1.26%, but this was up by 13.86% over a month. Three-month performance surged to 38.95% while six-month performance rose 19.07%. The stock gained 10.66% in the past year, while it has gained 0.82% so far this year. A look at the trailing 12-month EPS for XRX yields -0.19 with Next year EPS estimates of 2.43. For the next quarter, that number is 0.35. This implies an EPS growth rate of 14.84% for this year and 16.27% for next year.

Float and Shares Shorts:

At present, 123.14 million XRX shares are outstanding with a float of 113.62 million shares on hand for trading. On Jan 31, 2024, short shares totaled 10.23 million, which was 8.31% higher than short shares on Dec 29, 2023. In addition to LXRX as the firm’s Lexicon Pharmaceuticals, Inc., RXRX serves as its Recursion Pharmaceuticals, Inc..

Institutional Ownership:

Through their ownership of 92.21% of XRX’s outstanding shares, institutional investors have majority control over the company.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for XRX since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential. With XRX analysts setting a high price target of $19.00 and a low target of $13.90, the average target price over the next 12 months is $16.48. Based on these targets, XRX could surge 2.81% to reach the target high and fall by -24.78% to reach the target low. Reaching the average price target will result in a decline of -10.82% from current levels.

Dividends & Yield:

In terms of dividends, XRX has a current ratio of $1.0, which is $1.0 over the trailing 12-months, while a dividend of $1.0 is likely to be paid on average over the next five years. Dividend yield is another indicator that appeals to many investors, and XRX currently yields $5.41. In the past year, XRX’s dividend yield has been $5.41, but when looking at the stock over the past five years, its yield has been $5.02. Accordingly, XRX has a current buyback yield of $23.9. This was $23.9 for the TTM, and it was $13.68 for the past five years.

Summary of Insider Activity:

Insiders traded XRX stock several times over the past three months with 2 Buys and 2 Sells. In these transactions, 124,751 shares were bought while 124,751 shares were sold. The number of buy transactions has increased to 11 while that of sell transactions has risen to 15 over the past year. The total number of shares bought during that period was 328,897 while 34,629,208 shares were sold.